Compare $MDLN vs $MMED | Chartloom

Compare

$MDLN vs $MMED

Medline Inc · MiniMed Group Inc

MDLN

Medline Inc

MMED

MiniMed Group Inc

Compare $MDLN vs $MMED

Comparing Medline Inc and MiniMed Group Inc

MDLNMedline Inc

MMEDMiniMed Group Inc

MDLNMedline Inc

Market cap

$47.63B

P/E (TTM)

44.92x

Forward P/E (NTM)

24.12x

Forward P/S (NTM)

1.44x

Rev growth (TTM)

—

YTD performance

-10.7%

52W performance

-11.6%

FCF yield

3.2%

MMEDMiniMed Group Inc

Market cap

$5.54B

P/E (TTM)

—

Forward P/E (NTM)

24.86x

Forward P/S (NTM)

1.56x

Rev growth (TTM)

—

YTD performance

6.6%

52W performance

6.6%

FCF yield

-5.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MDLN

MMED

Detailed metrics comparison

MDLN

Medline Inc

MMED

MiniMed Group Inc

Market Cap

MDLN$47.63B

MMED$5.54B

Enterprise Value

MDLN$57.88B

MMED$5.33B

Price

MDLN$36.26

MMED$19.71

P/E Ratio

MDLN44.92x

MMEDN/A

P/S Ratio

MDLN1.59x

MMED3.29x

EV/Sales

MDLN1.93x

MMED3.17x

EV/EBITDA

MDLN17.66x

MMED0.00x

P/B Ratio

MDLN4.05x

MMED1.53x

P/FCF Ratio

MDLN30.81x

MMEDN/A

EV/FCF

MDLN37.44x

MMED-16.81x

PEG Ratio

MDLN3.82x

MMEDN/A

Forward P/E (NTM)

MDLN24.12x

MMED24.86x

Forward P/S (NTM)

MDLN1.44x

MMED1.56x

Revenue (TTM)

MDLN$29.94B

MMED$1.68B

Revenue Growth (YoY)

MDLNN/A

MMEDN/A

Forward Rev Growth

MDLN7.8%

MMED8.2%

Gross Margin (TTM)

MDLN26.2%

MMED56.3%

Operating Margin (TTM)

MDLN6.0%

MMED0.0%

EBITDA Margin (TTM)

MDLN10.9%

MMED-0.1%

Net Margin (TTM)

MDLN2.3%

MMED-11.0%

FCF Margin (TTM)

MDLN5.2%

MMED-18.9%

Net Income (TTM)

MDLN$695M

MMED$-185M

FCF (TTM)

MDLN$1.55B

MMED$-317M

EPS (TTM)

MDLN$0.81

MMED-$0.66

ROE (TTM)

MDLN5.5%

MMED0.0%

ROA (TTM)

MDLN1.8%

MMED0.0%

ROIC (TTM)

MDLN2.6%

MMED0.0%

Cash

MDLN$2.33B

MMED$207M

Debt

MDLN$12.58B

MMED$0

Net Cash/Debt

MDLN$-10.25B

MMED$207M

Current Ratio (TTM)

MDLN4.33x

MMED1.81x

Quick Ratio (TTM)

MDLN2.61x

MMED1.36x

Debt/Equity (TTM)

MDLN1.09x

MMED0.00x

Debt/Assets (TTM)

MDLN0.0%

MMED0.0%

Interest Coverage (TTM)

MDLNN/A

MMEDN/A

Net Debt/EBITDA (TTM)

MDLN0.00x

MMED0.00x

Beta

MDLN0.94

MMED0.16

52W Performance

MDLN-11.6%

MMED6.6%

YTD Performance

MDLN-10.7%

MMED6.6%

% from 52W High

MDLN-28.7%

MMED-19.3%

% from 52W Low

MDLN15.1%

MMED85.1%

Asset Turnover (TTM)

MDLN0.78x

MMED0.00x

FCF Yield (TTM)

MDLN3.2%

MMED-5.7%

Earnings Yield (TTM)

MDLN1.5%

MMED-3.3%

Dividend Yield (TTM)

MDLNN/A

MMEDN/A

Rule of 40

MDLN5.2

MMED-18.9

EV/GP/RG

MDLN0.72

MMED0.05

Ticker research

View MDLN research View MMED research

Metric	MDLN Medline Inc	MMED MiniMed Group Inc
Market & Valuation
Market Cap	$47.63B	$5.54B
Enterprise Value	$57.88B	$5.33B
Price	$36.26	$19.71
P/E Ratio	44.92x	N/A
P/S Ratio	1.59x	3.29x
EV/Sales	1.93x	3.17x
EV/EBITDA	17.66x	0.00x
P/B Ratio	4.05x	1.53x
P/FCF Ratio	30.81x	N/A
EV/FCF	37.44x	-16.81x
PEG Ratio	3.82x	N/A
Forward P/E (NTM)	24.12x	24.86x
Forward P/S (NTM)	1.44x	1.56x
Revenue & Growth
Revenue (TTM)	$29.94B	$1.68B
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	7.8%	8.2%
Profitability
Gross Margin (TTM)	26.2%	56.3%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.9%	-0.1%
Net Margin (TTM)	2.3%	-11.0%
FCF Margin (TTM)	5.2%	-18.9%
Net Income (TTM)	$695M	$-185M
FCF (TTM)	$1.55B	$-317M
EPS (TTM)	$0.81	-$0.66
ROE (TTM)	5.5%	0.0%
ROA (TTM)	1.8%	0.0%
ROIC (TTM)	2.6%	0.0%
Financial Health
Cash	$2.33B	$207M
Debt	$12.58B	$0
Net Cash/Debt	$-10.25B	$207M
Current Ratio (TTM)	4.33x	1.81x
Quick Ratio (TTM)	2.61x	1.36x
Debt/Equity (TTM)	1.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.16
52W Performance	-11.6%	6.6%
YTD Performance	-10.7%	6.6%
% from 52W High	-28.7%	-19.3%
% from 52W Low	15.1%	85.1%
Efficiency & Yields
Asset Turnover (TTM)	0.78x	0.00x
FCF Yield (TTM)	3.2%	-5.7%
Earnings Yield (TTM)	1.5%	-3.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.2	-18.9
EV/GP/RG	0.72	0.05
Ticker research	View MDLN research	View MMED research

Valuation

P/E Ratio

MDLN

44.92x

P/S Ratio

MDLN

1.59x

MMED

3.29x

EV/FCF

MMED

-16.81x

MDLN

37.44x

Growth & revenue

Forward Revenue Growth

MMED

8.2%

MDLN

7.8%

Profitability & performance

Gross Margin

MMED

56.3%

MDLN

26.2%

ROE

MDLN

5.5%

MMED

0.0%

FCF Yield %

MDLN

3.2%

MMED

-5.7%

52-Week Performance

MMED

6.6%

MDLN

-11.6%

Detailed metrics comparison

MDLN

Medline Inc

MMED

MiniMed Group Inc

Market Cap

MDLN$47.63B

MMED$5.54B

Enterprise Value

MDLN$57.88B

MMED$5.33B

Price

MDLN$36.26

MMED$19.71

P/E Ratio

MDLN44.92x

MMEDN/A

P/S Ratio

MDLN1.59x

MMED3.29x

EV/Sales

MDLN1.93x

MMED3.17x

EV/EBITDA

MDLN17.66x

MMED0.00x

P/B Ratio

MDLN4.05x

MMED1.53x

P/FCF Ratio

MDLN30.81x

MMEDN/A

EV/FCF

MDLN37.44x

MMED-16.81x

PEG Ratio

MDLN3.82x

MMEDN/A

Forward P/E (NTM)

MDLN24.12x

MMED24.86x

Forward P/S (NTM)

MDLN1.44x

MMED1.56x

Revenue (TTM)

MDLN$29.94B

MMED$1.68B

Revenue Growth (YoY)

MDLNN/A

MMEDN/A

Forward Rev Growth

MDLN7.8%

MMED8.2%

Gross Margin (TTM)

MDLN26.2%

MMED56.3%

Operating Margin (TTM)

MDLN6.0%

MMED0.0%

EBITDA Margin (TTM)

MDLN10.9%

MMED-0.1%

Net Margin (TTM)

MDLN2.3%

MMED-11.0%

FCF Margin (TTM)

MDLN5.2%

MMED-18.9%

Net Income (TTM)

MDLN$695M

MMED$-185M

FCF (TTM)

MDLN$1.55B

MMED$-317M

EPS (TTM)

MDLN$0.81

MMED-$0.66

ROE (TTM)

MDLN5.5%

MMED0.0%

ROA (TTM)

MDLN1.8%

MMED0.0%

ROIC (TTM)

MDLN2.6%

MMED0.0%

Cash

MDLN$2.33B

MMED$207M

Debt

MDLN$12.58B

MMED$0

Net Cash/Debt

MDLN$-10.25B

MMED$207M

Current Ratio (TTM)

MDLN4.33x

MMED1.81x

Quick Ratio (TTM)

MDLN2.61x

MMED1.36x

Debt/Equity (TTM)

MDLN1.09x

MMED0.00x

Debt/Assets (TTM)

MDLN0.0%

MMED0.0%

Interest Coverage (TTM)

MDLNN/A

MMEDN/A

Net Debt/EBITDA (TTM)

MDLN0.00x

MMED0.00x

Beta

MDLN0.94

MMED0.16

52W Performance

MDLN-11.6%

MMED6.6%

YTD Performance

MDLN-10.7%

MMED6.6%

% from 52W High

MDLN-28.7%

MMED-19.3%

% from 52W Low

MDLN15.1%

MMED85.1%

Asset Turnover (TTM)

MDLN0.78x

MMED0.00x

FCF Yield (TTM)

MDLN3.2%

MMED-5.7%

Earnings Yield (TTM)

MDLN1.5%

MMED-3.3%

Dividend Yield (TTM)

MDLNN/A

MMEDN/A

Rule of 40

MDLN5.2

MMED-18.9

EV/GP/RG

MDLN0.72

MMED0.05

Ticker research

View MDLN research View MMED research

Metric	MDLN Medline Inc	MMED MiniMed Group Inc
Market & Valuation
Market Cap	$47.63B	$5.54B
Enterprise Value	$57.88B	$5.33B
Price	$36.26	$19.71
P/E Ratio	44.92x	N/A
P/S Ratio	1.59x	3.29x
EV/Sales	1.93x	3.17x
EV/EBITDA	17.66x	0.00x
P/B Ratio	4.05x	1.53x
P/FCF Ratio	30.81x	N/A
EV/FCF	37.44x	-16.81x
PEG Ratio	3.82x	N/A
Forward P/E (NTM)	24.12x	24.86x
Forward P/S (NTM)	1.44x	1.56x
Revenue & Growth
Revenue (TTM)	$29.94B	$1.68B
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	7.8%	8.2%
Profitability
Gross Margin (TTM)	26.2%	56.3%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.9%	-0.1%
Net Margin (TTM)	2.3%	-11.0%
FCF Margin (TTM)	5.2%	-18.9%
Net Income (TTM)	$695M	$-185M
FCF (TTM)	$1.55B	$-317M
EPS (TTM)	$0.81	-$0.66
ROE (TTM)	5.5%	0.0%
ROA (TTM)	1.8%	0.0%
ROIC (TTM)	2.6%	0.0%
Financial Health
Cash	$2.33B	$207M
Debt	$12.58B	$0
Net Cash/Debt	$-10.25B	$207M
Current Ratio (TTM)	4.33x	1.81x
Quick Ratio (TTM)	2.61x	1.36x
Debt/Equity (TTM)	1.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.16
52W Performance	-11.6%	6.6%
YTD Performance	-10.7%	6.6%
% from 52W High	-28.7%	-19.3%
% from 52W Low	15.1%	85.1%
Efficiency & Yields
Asset Turnover (TTM)	0.78x	0.00x
FCF Yield (TTM)	3.2%	-5.7%
Earnings Yield (TTM)	1.5%	-3.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.2	-18.9
EV/GP/RG	0.72	0.05
Ticker research	View MDLN research	View MMED research